

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * exogenous drug catabolic process (GO:0042738) | 9.87030983 |
| 2 | * drug catabolic process (GO:0042737) | 8.85913601 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.61283835 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 7.95021421 |
| 5 | cellular glucuronidation (GO:0052695) | 7.87931589 |
| 6 | glucuronate metabolic process (GO:0019585) | 7.54608507 |
| 7 | uronic acid metabolic process (GO:0006063) | 7.54608507 |
| 8 | regulation of fibrinolysis (GO:0051917) | 7.53313087 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 7.47399446 |
| 10 | glyoxylate metabolic process (GO:0046487) | 7.25770013 |
| 11 | urea metabolic process (GO:0019627) | 7.01968951 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.46398977 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 6.46398977 |
| 14 | nitrogen cycle metabolic process (GO:0071941) | 6.40983390 |
| 15 | fibrinolysis (GO:0042730) | 6.39400247 |
| 16 | * drug metabolic process (GO:0017144) | 6.27084062 |
| 17 | bile acid biosynthetic process (GO:0006699) | 6.13015976 |
| 18 | bile acid metabolic process (GO:0008206) | 6.10190023 |
| 19 | bile acid and bile salt transport (GO:0015721) | 6.08060791 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 6.02499983 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.02499983 |
| 22 | negative regulation of sterol transport (GO:0032372) | 5.85062955 |
| 23 | negative regulation of cholesterol transport (GO:0032375) | 5.85062955 |
| 24 | phenylpropanoid metabolic process (GO:0009698) | 5.84780809 |
| 25 | urea cycle (GO:0000050) | 5.69643514 |
| 26 | ethanol oxidation (GO:0006069) | 5.60406389 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 5.52450002 |
| 28 | amino-acid betaine metabolic process (GO:0006577) | 5.40705008 |
| 29 | hormone catabolic process (GO:0042447) | 5.17479668 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.08801595 |
| 31 | daunorubicin metabolic process (GO:0044597) | 5.00385722 |
| 32 | polyketide metabolic process (GO:0030638) | 5.00385722 |
| 33 | doxorubicin metabolic process (GO:0044598) | 5.00385722 |
| 34 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.92504742 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.91115284 |
| 36 | protein carboxylation (GO:0018214) | 4.91115284 |
| 37 | aromatic amino acid family catabolic process (GO:0009074) | 4.90619169 |
| 38 | negative regulation of blood coagulation (GO:0030195) | 4.88807567 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.88807567 |
| 40 | phospholipid efflux (GO:0033700) | 4.85875590 |
| 41 | blood coagulation, intrinsic pathway (GO:0007597) | 4.84037316 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 4.76981969 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.74677924 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 4.68029093 |
| 45 | * fat-soluble vitamin biosynthetic process (GO:0042362) | 4.67438312 |
| 46 | glycine metabolic process (GO:0006544) | 4.64559928 |
| 47 | regulation of complement activation (GO:0030449) | 4.64003109 |
| 48 | heme transport (GO:0015886) | 4.59719497 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.56755843 |
| 50 | flavonoid metabolic process (GO:0009812) | 4.53001075 |
| 51 | intestinal cholesterol absorption (GO:0030299) | 4.51906081 |
| 52 | ethanol metabolic process (GO:0006067) | 4.48611924 |
| 53 | negative regulation of coagulation (GO:0050819) | 4.46098189 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.45841257 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.45841257 |
| 56 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.44052268 |
| 57 | regulation of plasminogen activation (GO:0010755) | 4.34850063 |
| 58 | negative regulation of wound healing (GO:0061045) | 4.30684289 |
| 59 | primary alcohol catabolic process (GO:0034310) | 4.30487972 |
| 60 | * oxidative demethylation (GO:0070989) | 4.27571870 |
| 61 | alpha-linolenic acid metabolic process (GO:0036109) | 4.23406560 |
| 62 | arginine metabolic process (GO:0006525) | 4.18582948 |
| 63 | high-density lipoprotein particle remodeling (GO:0034375) | 4.11456740 |
| 64 | drug transmembrane transport (GO:0006855) | 4.07770903 |
| 65 | negative regulation of lipase activity (GO:0060192) | 4.04211114 |
| 66 | cholesterol efflux (GO:0033344) | 4.03780481 |
| 67 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.96824448 |
| 68 | response to mercury ion (GO:0046689) | 3.90292915 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 3.87730783 |
| 70 | L-methionine salvage (GO:0071267) | 3.81216656 |
| 71 | L-methionine biosynthetic process (GO:0071265) | 3.81216656 |
| 72 | amino acid salvage (GO:0043102) | 3.81216656 |
| 73 | intestinal absorption (GO:0050892) | 3.81145875 |
| 74 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.80188255 |
| 75 | * xenobiotic metabolic process (GO:0006805) | 3.77923989 |
| 76 | macromolecular complex remodeling (GO:0034367) | 3.77433586 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.77433586 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 3.77433586 |
| 79 | positive regulation of blood coagulation (GO:0030194) | 3.74844822 |
| 80 | positive regulation of hemostasis (GO:1900048) | 3.74844822 |
| 81 | drug transport (GO:0015893) | 3.73188061 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71465612 |
| 83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71465612 |
| 84 | coenzyme catabolic process (GO:0009109) | 3.71300552 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 3.61968550 |
| 86 | tyrosine metabolic process (GO:0006570) | 3.52606250 |
| 87 | indole-containing compound catabolic process (GO:0042436) | 3.52148229 |
| 88 | indolalkylamine catabolic process (GO:0046218) | 3.52148229 |
| 89 | tryptophan catabolic process (GO:0006569) | 3.52148229 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.51661394 |
| 91 | positive regulation of coagulation (GO:0050820) | 3.50878226 |
| 92 | reverse cholesterol transport (GO:0043691) | 3.46777072 |
| 93 | monocarboxylic acid catabolic process (GO:0072329) | 3.44769157 |
| 94 | lipoprotein transport (GO:0042953) | 3.43969161 |
| 95 | protein activation cascade (GO:0072376) | 3.43566340 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.42011688 |
| 97 | fatty acid catabolic process (GO:0009062) | 3.38793969 |
| 98 | regulation of lipoprotein particle clearance (GO:0010984) | 3.36511153 |
| 99 | negative regulation of lipid transport (GO:0032369) | 3.34069889 |
| 100 | carnitine metabolic process (GO:0009437) | 3.33641802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42550956 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.03912448 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.50182300 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.37968547 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.76665977 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.52501820 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.80317961 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.73773983 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.03341291 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.88318511 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.38869820 |
| 12 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.19473369 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06500967 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.00878202 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1327377 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.82727820 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69023117 |
| 18 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.62135159 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57169518 |
| 20 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.55878490 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54582741 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51372105 |
| 23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41362814 |
| 24 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.36930032 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35180712 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26362075 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25100948 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19656036 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13882512 |
| 30 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.12737733 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11782530 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11432986 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10359486 |
| 34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08772019 |
| 35 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05081426 |
| 36 | CBP_21632823_ChIP-Seq_H3396_Human | 1.02198215 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00997025 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99433546 |
| 39 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.93686741 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93384717 |
| 41 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92460898 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91730715 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90876209 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90099083 |
| 45 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89855375 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89302295 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86917143 |
| 48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86743055 |
| 49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84808667 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84727915 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84199483 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82320386 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82042507 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81624519 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.77939074 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77691282 |
| 57 | AR_20517297_ChIP-Seq_VCAP_Human | 0.75539996 |
| 58 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.74521973 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.73839960 |
| 60 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.73714504 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73639699 |
| 62 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.73636814 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71320817 |
| 64 | NFYA_21822215_ChIP-Seq_K562_Human | 0.67257491 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66021222 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.65960263 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.65746629 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65735782 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65735782 |
| 70 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.65463602 |
| 71 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64850430 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.64849821 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.63761988 |
| 74 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.63553600 |
| 75 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63124340 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.62346951 |
| 77 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61952489 |
| 78 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.61300613 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.60883084 |
| 80 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.60418868 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.59585390 |
| 82 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.57988256 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.57899949 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57498406 |
| 85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.57261982 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.56348714 |
| 87 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.56123437 |
| 88 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.55360876 |
| 89 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.54948220 |
| 90 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54808883 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.54706746 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54070694 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.54027373 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53648236 |
| 95 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.53077909 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.52813769 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.52764500 |
| 98 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.52694805 |
| 99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.52067237 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.51533791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.82581868 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.50816858 |
| 3 | MP0005365_abnormal_bile_salt | 6.23555959 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 4.69492328 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.27533981 |
| 6 | MP0003252_abnormal_bile_duct | 4.12031199 |
| 7 | MP0003195_calcinosis | 3.77168058 |
| 8 | MP0003868_abnormal_feces_composition | 3.53818770 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.43799474 |
| 10 | MP0009840_abnormal_foam_cell | 3.28133781 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.71133134 |
| 12 | MP0009697_abnormal_copulation | 2.36783868 |
| 13 | MP0005332_abnormal_amino_acid | 2.31416600 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.26784228 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 10.4338486 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.94523554 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 1.90162451 |
| 18 | MP0000609_abnormal_liver_physiology | 1.78503953 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.69630720 |
| 20 | MP0001764_abnormal_homeostasis | 1.61368927 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.56603817 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.28145720 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.22602863 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.17865871 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12790777 |
| 26 | MP0005408_hypopigmentation | 1.03840575 |
| 27 | MP0005451_abnormal_body_composition | 1.01756063 |
| 28 | MP0005670_abnormal_white_adipose | 0.97876395 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 0.90027927 |
| 30 | MP0009053_abnormal_anal_canal | 0.86772982 |
| 31 | MP0000598_abnormal_liver_morphology | 0.86160895 |
| 32 | MP0003879_abnormal_hair_cell | 0.84364695 |
| 33 | MP0009642_abnormal_blood_homeostasis | 0.83405159 |
| 34 | MP0008469_abnormal_protein_level | 0.80691467 |
| 35 | MP0003718_maternal_effect | 0.77983849 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 0.77633575 |
| 37 | MP0002971_abnormal_brown_adipose | 0.75596471 |
| 38 | MP0005535_abnormal_body_temperature | 0.73920963 |
| 39 | MP0005376_homeostasis/metabolism_phenot | 0.70758021 |
| 40 | MP0004147_increased_porphyrin_level | 0.70194385 |
| 41 | MP0009763_increased_sensitivity_to | 0.66656071 |
| 42 | MP0009764_decreased_sensitivity_to | 0.66069633 |
| 43 | MP0003638_abnormal_response/metabolism_ | 0.65997369 |
| 44 | MP0010368_abnormal_lymphatic_system | 0.63857925 |
| 45 | MP0005395_other_phenotype | 0.62259607 |
| 46 | MP0000604_amyloidosis | 0.61131643 |
| 47 | MP0010155_abnormal_intestine_physiology | 0.60557747 |
| 48 | MP0005409_darkened_coat_color | 0.58984829 |
| 49 | MP0003011_delayed_dark_adaptation | 0.57723705 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.55964223 |
| 51 | MP0001661_extended_life_span | 0.55446336 |
| 52 | MP0005448_abnormal_energy_balance | 0.54551155 |
| 53 | MP0004264_abnormal_extraembryonic_tissu | 0.54396034 |
| 54 | MP0002136_abnormal_kidney_physiology | 0.51724079 |
| 55 | MP0003186_abnormal_redox_activity | 0.51529191 |
| 56 | MP0005334_abnormal_fat_pad | 0.49151988 |
| 57 | MP0005464_abnormal_platelet_physiology | 0.47201544 |
| 58 | MP0005023_abnormal_wound_healing | 0.46529755 |
| 59 | MP0005266_abnormal_metabolism | 0.45842628 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.45347709 |
| 61 | MP0008872_abnormal_physiological_respon | 0.44668500 |
| 62 | MP0005166_decreased_susceptibility_to | 0.44546465 |
| 63 | MP0002132_abnormal_respiratory_system | 0.43387691 |
| 64 | MP0003300_gastrointestinal_ulcer | 0.43282302 |
| 65 | MP0000249_abnormal_blood_vessel | 0.42654695 |
| 66 | MP0003690_abnormal_glial_cell | 0.42159345 |
| 67 | MP0001915_intracranial_hemorrhage | 0.41007123 |
| 68 | MP0005187_abnormal_penis_morphology | 0.39422078 |
| 69 | MP0001756_abnormal_urination | 0.39384429 |
| 70 | MP0008874_decreased_physiological_sensi | 0.39154830 |
| 71 | MP0003959_abnormal_lean_body | 0.38540954 |
| 72 | MP0009115_abnormal_fat_cell | 0.37253077 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 0.36036563 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.35659436 |
| 75 | MP0009785_altered_susceptibility_to | 0.34334262 |
| 76 | MP0001845_abnormal_inflammatory_respons | 0.34162916 |
| 77 | MP0003329_amyloid_beta_deposits | 0.33158757 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.32277921 |
| 79 | MP0002168_other_aberrant_phenotype | 0.31901849 |
| 80 | MP0003953_abnormal_hormone_level | 0.30800980 |
| 81 | MP0009379_abnormal_foot_pigmentation | 0.29643372 |
| 82 | MP0001881_abnormal_mammary_gland | 0.29509592 |
| 83 | MP0000538_abnormal_urinary_bladder | 0.27637520 |
| 84 | MP0001664_abnormal_digestion | 0.26680594 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.25648720 |
| 86 | MP0001663_abnormal_digestive_system | 0.25261525 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.25018475 |
| 88 | MP0005164_abnormal_response_to | 0.23647890 |
| 89 | MP0004883_abnormal_blood_vessel | 0.22335560 |
| 90 | MP0008873_increased_physiological_sensi | 0.21820796 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.21611197 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.20971908 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.20404077 |
| 94 | MP0005647_abnormal_sex_gland | 0.20017304 |
| 95 | MP0001851_eye_inflammation | 0.19692114 |
| 96 | MP0004043_abnormal_pH_regulation | 0.19405484 |
| 97 | MP0002970_abnormal_white_adipose | 0.18612156 |
| 98 | MP0002822_catalepsy | 0.18178541 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.17398244 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.17322321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.78322273 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 8.98195733 |
| 3 | Deep venous thrombosis (HP:0002625) | 8.39803114 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.99376811 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.78415884 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 6.54561131 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.21549931 |
| 8 | Complement deficiency (HP:0004431) | 6.08742141 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.17782898 |
| 10 | Abnormality of complement system (HP:0005339) | 5.17403992 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 5.11504476 |
| 12 | Fat malabsorption (HP:0002630) | 5.06115459 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 5.01683366 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.90656754 |
| 15 | Xanthomatosis (HP:0000991) | 4.84508130 |
| 16 | Joint hemorrhage (HP:0005261) | 4.52462505 |
| 17 | Steatorrhea (HP:0002570) | 4.18067709 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12423811 |
| 19 | Hyperglycinuria (HP:0003108) | 4.07568452 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06561412 |
| 21 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.99321968 |
| 22 | Rickets (HP:0002748) | 3.98470496 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.78378825 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.78378825 |
| 25 | Hydroxyprolinuria (HP:0003080) | 3.68653268 |
| 26 | Abnormality of proline metabolism (HP:0010907) | 3.68653268 |
| 27 | Generalized aminoaciduria (HP:0002909) | 3.68435028 |
| 28 | Hyperammonemia (HP:0001987) | 3.65736640 |
| 29 | Glomerulonephritis (HP:0000099) | 3.64443844 |
| 30 | Abnormality of vitamin metabolism (HP:0100508) | 3.60042608 |
| 31 | Hyperglycinemia (HP:0002154) | 3.51732144 |
| 32 | Abnormality of urine glucose concentration (HP:0011016) | 3.33980106 |
| 33 | Glycosuria (HP:0003076) | 3.33980106 |
| 34 | Nephritis (HP:0000123) | 3.17934203 |
| 35 | Hemorrhage of the eye (HP:0011885) | 3.11078366 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.09833731 |
| 37 | Vascular calcification (HP:0004934) | 3.09816630 |
| 38 | Hyperphosphaturia (HP:0003109) | 3.09555429 |
| 39 | Spontaneous abortion (HP:0005268) | 3.00677212 |
| 40 | Osteomalacia (HP:0002749) | 2.97402615 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.96743443 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.94301138 |
| 43 | Malnutrition (HP:0004395) | 2.87045682 |
| 44 | Epidermoid cyst (HP:0200040) | 2.85339610 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.80446488 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77679303 |
| 47 | Acanthocytosis (HP:0001927) | 2.74632969 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.73635617 |
| 49 | Abnormal urine phosphate concentration (HP:0012599) | 2.69954384 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.69089610 |
| 51 | Mitral stenosis (HP:0001718) | 2.62863373 |
| 52 | Metabolic acidosis (HP:0001942) | 2.57592678 |
| 53 | Hyperbilirubinemia (HP:0002904) | 2.57452691 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52962308 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.45553564 |
| 56 | Poikilocytosis (HP:0004447) | 2.44840423 |
| 57 | Irritability (HP:0000737) | 2.42351085 |
| 58 | Abnormality of methionine metabolism (HP:0010901) | 2.37587726 |
| 59 | Gingival bleeding (HP:0000225) | 2.36692476 |
| 60 | Bifid scrotum (HP:0000048) | 2.32744071 |
| 61 | Hypophosphatemic rickets (HP:0004912) | 2.32346482 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.27830621 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.21926414 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 2.17263484 |
| 65 | Hypophosphatemia (HP:0002148) | 2.13690492 |
| 66 | Elevated alkaline phosphatase (HP:0003155) | 2.09760088 |
| 67 | Increased mean platelet volume (HP:0011877) | 2.09642877 |
| 68 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.07856411 |
| 69 | Hypochromic microcytic anemia (HP:0004840) | 2.05201000 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.04000817 |
| 71 | Purpura (HP:0000979) | 2.03687723 |
| 72 | Alkalosis (HP:0001948) | 2.01698883 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 1.99599921 |
| 74 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97883319 |
| 75 | Nausea (HP:0002018) | 1.91059434 |
| 76 | Abnormal platelet volume (HP:0011876) | 1.90386887 |
| 77 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88820277 |
| 78 | Lethargy (HP:0001254) | 1.87723653 |
| 79 | Nephrolithiasis (HP:0000787) | 1.87686848 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 1.86985013 |
| 81 | Hypoglycemic coma (HP:0001325) | 1.85455392 |
| 82 | Thrombophlebitis (HP:0004418) | 1.84260092 |
| 83 | Pulmonary embolism (HP:0002204) | 1.84017538 |
| 84 | Abnormal gallbladder physiology (HP:0012438) | 1.83135358 |
| 85 | Cholecystitis (HP:0001082) | 1.83135358 |
| 86 | Pigmentary retinal degeneration (HP:0001146) | 1.81616619 |
| 87 | Widely patent fontanelles and sutures (HP:0004492) | 1.80049023 |
| 88 | Ketosis (HP:0001946) | 1.77550730 |
| 89 | Cholelithiasis (HP:0001081) | 1.75835207 |
| 90 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.75693654 |
| 91 | Abnormal tarsal ossification (HP:0008369) | 1.72586988 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72097966 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 1.72097966 |
| 94 | Abnormality of vitamin B metabolism (HP:0004340) | 1.72084926 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 1.71264711 |
| 96 | Skin nodule (HP:0200036) | 1.70655569 |
| 97 | Hypochromic anemia (HP:0001931) | 1.68570569 |
| 98 | Joint swelling (HP:0001386) | 1.68494270 |
| 99 | Abnormal platelet function (HP:0011869) | 1.68295795 |
| 100 | Impaired platelet aggregation (HP:0003540) | 1.68295795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.58235398 |
| 2 | ERN1 | 4.96388910 |
| 3 | RIPK1 | 4.31563105 |
| 4 | MST1R | 3.39364751 |
| 5 | PIK3CG | 2.96036903 |
| 6 | MAP3K12 | 2.88086910 |
| 7 | FGFR4 | 2.54249808 |
| 8 | TYK2 | 2.46467669 |
| 9 | PRPF4B | 2.39978600 |
| 10 | MAP3K2 | 2.20835728 |
| 11 | PRKG2 | 1.97969204 |
| 12 | MAP3K3 | 1.95801332 |
| 13 | EPHA3 | 1.84691829 |
| 14 | PRKACG | 1.79662374 |
| 15 | IRAK3 | 1.72154914 |
| 16 | ABL2 | 1.68881570 |
| 17 | PIK3CA | 1.64074714 |
| 18 | MYLK | 1.63779796 |
| 19 | FGFR3 | 1.50857451 |
| 20 | TBK1 | 1.48815660 |
| 21 | PRKAA2 | 1.41268866 |
| 22 | EPHA4 | 1.39658067 |
| 23 | MAPK11 | 1.36266404 |
| 24 | NEK9 | 1.34443945 |
| 25 | PTK6 | 1.29457646 |
| 26 | PDPK1 | 1.22635878 |
| 27 | PINK1 | 1.21358506 |
| 28 | MAP3K1 | 1.14986411 |
| 29 | NLK | 1.13972322 |
| 30 | EPHA2 | 1.13263618 |
| 31 | ERBB2 | 1.11945293 |
| 32 | PRKCZ | 1.08401127 |
| 33 | NTRK3 | 1.05864021 |
| 34 | MET | 1.05590116 |
| 35 | KSR2 | 1.05589517 |
| 36 | IGF1R | 1.04294801 |
| 37 | TESK2 | 1.00180310 |
| 38 | JAK1 | 0.95651997 |
| 39 | EPHB1 | 0.95479598 |
| 40 | MAP3K5 | 0.93377727 |
| 41 | MAP2K4 | 0.92240451 |
| 42 | JAK2 | 0.92011871 |
| 43 | DYRK1B | 0.89495967 |
| 44 | MAP3K11 | 0.88865854 |
| 45 | SIK1 | 0.85409182 |
| 46 | FER | 0.82227010 |
| 47 | PDK1 | 0.81664805 |
| 48 | TRIB3 | 0.80558766 |
| 49 | MAP3K10 | 0.79495659 |
| 50 | PDK2 | 0.78032213 |
| 51 | CDK6 | 0.77637043 |
| 52 | RET | 0.76806697 |
| 53 | BCR | 0.72268892 |
| 54 | GRK6 | 0.65517250 |
| 55 | AKT3 | 0.62336713 |
| 56 | MAP2K2 | 0.61618608 |
| 57 | MAP3K14 | 0.61478529 |
| 58 | BCKDK | 0.60868601 |
| 59 | PRKG1 | 0.60841174 |
| 60 | PRKCG | 0.59992872 |
| 61 | ZAP70 | 0.59689588 |
| 62 | * PRKCA | 0.58656196 |
| 63 | CASK | 0.58090980 |
| 64 | PIM2 | 0.56625821 |
| 65 | OXSR1 | 0.55603746 |
| 66 | CAMK2G | 0.52194797 |
| 67 | PRKCB | 0.51651118 |
| 68 | MAPKAPK3 | 0.51405074 |
| 69 | PRKAA1 | 0.49884868 |
| 70 | STK39 | 0.49726819 |
| 71 | CSF1R | 0.49594434 |
| 72 | LMTK2 | 0.48115982 |
| 73 | * PRKACA | 0.48037021 |
| 74 | TAOK2 | 0.47888138 |
| 75 | DAPK2 | 0.47661340 |
| 76 | SRC | 0.47372352 |
| 77 | FRK | 0.46701183 |
| 78 | BMPR2 | 0.46541668 |
| 79 | CAMKK2 | 0.45292946 |
| 80 | MAP3K6 | 0.44235527 |
| 81 | SCYL2 | 0.42891419 |
| 82 | MATK | 0.42482765 |
| 83 | ICK | 0.40759093 |
| 84 | TAOK1 | 0.39017738 |
| 85 | PDGFRA | 0.38666922 |
| 86 | STK24 | 0.38661372 |
| 87 | ERBB4 | 0.37271259 |
| 88 | INSRR | 0.34320869 |
| 89 | PIM1 | 0.33484664 |
| 90 | TAOK3 | 0.33483583 |
| 91 | GRK1 | 0.33183508 |
| 92 | PRKCD | 0.31946159 |
| 93 | MAPK4 | 0.31275191 |
| 94 | GSK3A | 0.28536985 |
| 95 | RPS6KA3 | 0.27051173 |
| 96 | MAP2K6 | 0.26835060 |
| 97 | FYN | 0.25996230 |
| 98 | YES1 | 0.24857913 |
| 99 | SGK1 | 0.24521475 |
| 100 | TNIK | 0.24352741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 5.53397574 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.97943417 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.80371343 |
| 4 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.23660757 |
| 5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.18758782 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.03584512 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.00112951 |
| 8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.90205907 |
| 9 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.88304355 |
| 10 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.81594931 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.58319689 |
| 12 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.52024398 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.44731675 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44679559 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23292546 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.20064884 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16146853 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.09470478 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03120001 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.93802293 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.92266429 |
| 22 | * Bile secretion_Homo sapiens_hsa04976 | 1.88887650 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.81918743 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76523484 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.72818306 |
| 26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.71923077 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.71499701 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61303080 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57108190 |
| 30 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51164768 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.32987014 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.24707482 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23723683 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14569095 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09783240 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08233007 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05782038 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04817835 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04075844 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03733227 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97382511 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91391759 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89229221 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87531043 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87164915 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81737456 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79308940 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79024661 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78358900 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78299307 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78111344 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74978963 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73577414 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72888836 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72489289 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.70403941 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56085327 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.50849681 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50398713 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49659788 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.43280253 |
| 62 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40837044 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38744783 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38566055 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35319939 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33849421 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.29719538 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29523051 |
| 69 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28726336 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24760120 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24503301 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23744586 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.17157532 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16498891 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.15352205 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12121833 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.11475798 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.09745793 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08626623 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08555699 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.07623251 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07615416 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.05003148 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.03725919 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01000736 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00912462 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00362895 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.2571671 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | -0.2227440 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2118190 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | -0.2109917 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2060541 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.2058121 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2027239 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1769658 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1571399 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1555742 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1081707 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0756017 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0198939 |

